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Macrophages play important  roles in  inflammation and  host defense against 
bacterial  infection.  The  metabolites of arachidonic acid  (20:4) 1 are  important 
modulators of these responses (1). When macrophages interact with stimuli such 
as an immune complex or a bacterium, phospholipases are activated and 20:4 is 
liberated from plasma  membrane phospholipids.  The free 20:4  is  then quanti- 
tatively oxygenated by either the lipoxygenase pathway to leukotriene C  (LTC) 
and hydroxyeicosatetranoic acids (HETEs) or along the cyclooxygenase pathway 
to prostaglandin  E2 (PGE2) and prostacyclin (PGI2) (2-5). 
Very little  is  known  about  the cellular events involved in  the  activation and 
control of 20:4 metabolism. We report here that bacterial LPS, at concentrations 
similar to that found in the blood of patients with gram-negative bacteremia (6) 
prime macrophages for a greatly increased capacity to secrete 20:4 metabolites. 
Materials and Methods 
Macrophage  Cultures.  Primary cultures of peritoneal macrophages were established 
from resident cells of specific pathogen-free female ICR mice (Trudeau Institute, Saranac 
Lake,  NY)  weighing  25-30  g  as  previously described (7).  Peritoneal cells  (~9  x  106 
cells/ml) in c~-MEM (Gibco, Grand Island, NY) containing 10%  FCS were added to 35- 
mm-diam plastic culture dishes (1 ml/dish) or to 12-mm glass coverslips (0.1 ml/coverlsip). 
After 2 h at 37°C in 95% air and 5% CO2, cultures were washed three times in calcium 
and magnesium-free phosphate buffered saline (PD) to remove nonadherent cells. Fresh 
c~-MEM plus 10% FCS (1  ml/dish) containing 0.5 uCi of 5,6,8,9,11,12,14,15-[3H]arachi  - 
donic acid ([~H]20:4;  sp act, 70 Ci/nmol; New England Nuclear, Boston, MA) was added, 
and the cells were incubated overnight (16 h) (8). Resident peritoneal macrophages were 
also harvested from Swiss-Webster nude mice (nu/nu)  (Charles River Laboratory, Wil- 
mington, MA). 
LPS  Determination.  All  reagents  and  culture  material  were  found to contain  <0.1 
ng/ml contaminating LPS using the limulus amebocyte lysate assay (Cape Cod Associates, 
Woods Hole, MA). 
Priming of Macrophages  with LPS.  Cells  were incubated at 37°C for 60 min (except 
where  indicated)  in  c~-MEM containing  Escherichia  coli  011 I:B4  LPS  (List  Biological 
Laboratories, Campbell, CA). LPS from E. coli 026:B6 (List Laboratories), S. typhimurium 
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(Calbiochem-Behring, La Jolla, CA) and S. typhosa (Difco Laboratories, Detroit MI), were 
also found to prime macrophages for enhanced 20:4 secretion, but most of the experiments 
reported here used LPS from E. coli 0111 :B4 (List Laboratories).  In experiments where 
the concentration  dependence of LPS was determined,  LPS was complexed  1:1  (wt/wt) 
with delipidated, pyrogen-free human serum albumin (HSA) (Abbot Laboratories, Irving, 
TX). 
Preparation of Unopsonized Zymosan.  Zymosan  was purchased  from  ICN  (Plainview, 
NY) and stock solutions in  PD were prepared according to the method of Bonney et al. 
(2). 
Preparation of Ligand-coated Particles.  Ligand-coated particles  were  prepared  as de- 
scribed previously (9).  Briefly, glass beads (8 •m;  Duke Scientific Corp.,  Palo Alto, CA) 
were  derivitized  with  DNP as  described  previously for  glass  coverslips  (10),  and  were 
suspended  in  PBS  at  50  mg/ml.  DNP-beads  did  not  trigger  the  release  of 20:4  from 
macrophages,  lgG-coated beads  (BIgG) or IgM-coated beads  (BIgM) were obtained  by 
incubating 10 mg of DNP-beads in 250 #1 of 10% FCS for 30 rain at 20°C with 25 ~g/ml 
of affinty-purified rabbit IgG anti-DNP (11), or with 3 ttl of murine monoclonal IgM anti- 
DNP ascites fluid  (12).  The beads  were  then  washed  three  times and  suspended  at  50 
mg/ml in PBS.  Complement-coated beads (BIgMC) were prepared  by incubating BIgM 
at 25 ~g/ml with 20% normal human serum for 15 min at 37°C followed by three washes 
in PBS. 
BIgMC were  shown  to  interact  both  C3b and  C3bi  receptors,  since the  attachment 
index of C3b- and C3bi-coated erythrocytes (EC3b, EC3bi) was markedly reduced (~85%) 
by pretreating  the cells with  BIgMC (9).  BIgM had little effect on the binding of EC3b 
and EC3bi (9). 
Treatment of Macrophages with Latex Particles.  Latex beads (1 #m) (Dow Chemical Co., 
Midland,  MI) were washed three  times in  PD.  The particles were centrifuged onto cell 
cultures at 800 g at a concentration of ~50 beads/cell. 
"Activation" of  Complement Receptors with L  ymphokines.  To obtain cells that were capable 
of ingesting C3-coated particles, macrophage monolayers were incubated at 37 °C for 16 
h in supernatants containing a lymphokine secreted by appropriately triggered T  lympho- 
cytes (TCF) (generously provided by Dr. Frank Griffin, University of Alabama, Birming- 
ham, AL) (13). Macrophages thus treated had a phagocytic index of 140 for complement- 
coated erythrocytes compared, with a phagocytic index of 18 h in untreated cells (9). 
Assay of Total [3H]20:4 Release.  Macrophages prelabelled with [SH]20:4 (New England 
Nuclear) were washed four times in PD and were then overlaid with  1 ml of serum-free 
c~-MEM.  Zymosan (160  ttg/ml),  BIgG (5  mg/ml),  PMA  (100  ng/ml),  and  A23187  (i0 
ug/ml) were added as indicated.  The cells were incubated at  37°C in 95%  air and  5% 
CO2  and  at  the  times  indicated  aliquots  of medium  were  removed  and  counted  in 
Hydrofluor (National Diagnostics, Inc., Somerville, N  J). The cells were washed in PD and 
scraped into 1 ml of Triton X-100. Portions of the cell lysates were assayed for radiolabel 
content, and protein was determined  by the method of Lowry et al.  (14) with  BSA as a 
standard. 
Quantitation of [3H]20:4 Metabolites.  The  20:4  metabolites  in  the  culture  medium 
were extracted by the method of Unger et al. (15). To  1 ml of medium was added  1 ml 
of ethanol and  10 ~1 of 88% (wt/wt) formic acid, and the resultant solution was extracted 
twice  with  1  ml  of chloroform  containing  0.005%  (wt/vol)  butylated  hydroxytoluene 
(Sigma  Chemical  Co.,  St.  Louis,  MO).  The  lower (chloroform) phases  were  combined, 
evaporated to dryness under nitrogen, and the residue was dissolved in the appropriate 
starting solvent for further purification by reverse-phase HPLC. 
Concentrated medium extracts were applied to a column of UItrasphere C-18 (4.6 mm 
x  25 cm) (Altex Scientific Inc.) (HPLC system  1). The column was eluted at a rate of 1 
ml/min with 60 ml of solvent 1 (methanol/0.01  M H.~PO4, 65:35, vol/vol, adjusted to pH 
5.4 with  ammonium  hydroxide), followed by 40  ml of solvent  2  (methanol/acetic acid, 
100:0.01,  vol/vol) (8,  16).  For the characterization  of the cyclooxygenase metabolites,  a 
duplicate  extract  was applied  on  HPLC  system  2  using  a  Waters  Fatty  Acid  Analysis 
Column  (Waters  Assoc.,  Milford,  MA).  Prostaglandins  were eluted  at  a  flow  rate  of 2 ADEREM  ET  AL.  167 
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F[CURE  1.  Effect of LPS on zymosan-induced 20:4 secretion from resident peritoneal mac- 
rophages. Macrophages were isolated and labeled with [~H]20:4.  The cells were then washed 
and overlaid with either a-MEM containing 1 t~g/ml LPS (A, O) or with a-MEM alone (['-1, x). 
After 60 rain at 37°C in 95% air/5% COs, the cells were treated with 160 ug/ml zymosan as 
indicated (A, I-3). At the specified times, duplicate aliquots of the medium were removed and 
counted. The cells were scraped twice in 0.5% Triton X-100, and the radiolabel and protein 
content of the cell lysates were determined. Values are expressed as percent of total cellular 
20:4 released into the medium, and are means of triplicate cultures. 
ml/min with 120 ml of solvent 3 (water/acetonitrile/benzene/acetic acid, 76.7:23:0.2:0.1, 
vol/vol/vol/vol), followed by 40  ml  of solvent  2  (8,  17). Fractions from  HPLC  were 
collected at 1-min intervals, and the radiolabel content of whole fractions or aliquots were 
measured  by  liquid  scintillation  counting  in  Hydrofluor. Corrections  were  made  for 
counting efficiency (~40%).  The recovery of 20:4 metabolites through extraction and 
purification procedures was monitored using radiolabeled standards (18). 
Materials.  All materials used were reagent grade. PMA was from Sigma Chemical Co. 
and A23187 was obtained from Calbiochem-Behring. 
Results 
Effect of Bacterial LPS on the 20:4 Cascade.  Resident peritoneal macrophages 
cultured  in  the  absence  of a  stimulus  constitutively secrete  low  levels of 20:4 
metabolites  into  the  medium  (Fig.  1).  When  these  cells  were  triggered  with 
zymosan (Fig.  1),  PMA  (Fig.  2),  immune complexes (Fig.  3), or the Ca  2+ iono- 
phore A23187  (Fig. 4), oxygenated 20:4 metabolites were secreted. E. coli LPS 
(1  #g/ml)  was  a  poor stimulus  of 20:4  metabolite  release (Fig.  1).  After a  lag 
period of 60-80 rain, there was a  gradual release of ~8% of cellular 20:4, with 
a maximum at  180 min. 
In contrast to the previous results, preincubation of cells with LPS for 60 min 
had a striking effect on the rate of 20:4 secreted in response to a second stimulus. 
Thus LPS-primed cells, challenged with zymosan, secreted 23% of their cellular 
20:4 by 20 min, compared with 6% released by cells that had not been treated 
with LPS (Fig.  1). LPS priming also increased the total amount of 20:4 secretion 
from the cells. Primed cells released 40% of their 20:4 in response to zymosan, 
while untreated cells were stimulated to secrete a maximum of 20% (Fig.  1). 
The priming effect was even more pronounced when the cells were stimulated 
with  PMA  (Fig.  2).  On  its  own,  PMA  triggered  the  release  of ~12%  of the 168  LIPOPOLYSACCHARIDE  PRIMING  OF  MACROPHAGES 
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FIGURE  2.  Effect of LPS  on  PMA-induced  20:4  secretion  from resident peritoneal  macro- 
phages.  Macrophages  were  isolated and  labeled with [Sill20:4  as in  Fig.  1.  Cells were  then 
treated with  100 ng/ml PMA as in Fig.  1 (A, F-I). 
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FIGURE  3.  Effect of LPS on immune  complex-triggered  20:4 secretion  from  resident peri- 
toneal macrophages.  As in Fig.  1, cells were overlaid with either c~-MEM containing  1 ~g/ml 
LPS (A, A, ©) or with a-MEM alone (Q, Fl, X), then challenged with 5 mg BIgG or with BDNP 
as indicated. Values were determined and are expressed as described in Fig.  1. 
cellular 20:4. However, when first preincubated in LPS for 60 min, 20:4 release 
in response to PMA was potentiated eight-fold at 20 min, and three-fold at 2 h 
(Fig.  2).  Similarly,  LPS also synergized  with  immune  complexes (Fig.  3),  and 
with the  Ca 2+ ionophore  A23187 (Fig.  4).  As can  be noted  from  Fig.  2 (inset) 
and  from  Figs.  1-3,  20:4  secretion only commenced after an  initial  lag phase 
when unprimed cells were stimulated. This lag phase was much reduced in LPS- 
treated cells. 
These data indicate that, while LPS alone is a poor trigger of the 20:4 cascade, 
it does prime  macrophages  for greatly enhanced  20:4  release in  response to a 
variety of particulate and soluble stimuli. 
Concentration Dependence and Temporal Response of LPS Effect.  The  concen- 
tration dependence of LPS-induced triggering of 20:4 release and LPS-induced 
priming of macrophages for enhanced 20:4 secretion with PMA was determined ADEREM  ET  AL. 
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FIGURE  4.  Effect  of LPS on  A23187-induced  20:4 secretion from resident peritoneal mac- 
rophages. Washed and preincubated for 60 rain in a-MEM  containing  ]  /~g/ml  LPS (x) or in 
c~-MEM alone (O), the ceils were challenged with  A23187) (l 0  #g/ml),  and 20:4 secretion was 
determined as in Fig.  l. 
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FIGURE  5.  Concentration dependence of LPS-induced 20:4 secretion and of LPS-priming of 
macrophages for enhanced 20:4  secretion in  response to  PMA. The  cells treated  with the 
indicated concentration of HSA-LPS suspended in a-MEM for 180 min, at which point 20:4 
release was assessed (x). Alternatively, cells were treated with the concentration of HSA-LPS 
indicated for 60 rain, after which the cells were challenged with 100 ng/ml PMA for a further 
120  min  (0).  The amount  of radiolabeled 20:4  released into the medium  was determined. 
Values are expressed as percent of total cellular 20:4 released into the medium, and are means 
of triplicate cultures. 
(Fig.  5).  Interestingly,  the  half-maximal  effects  of the  two  parameters  were 
different.  LPS-induced  20:4  secretion  had  a  K,/2 of  500  ng/ml,  while  LPS- 
dependent  printing  had a K,/2 of 10 ng/ml.  The  half-maximal  concentration  of 
LPS required for enhanced  20:4 secretion in response to a second stimulus was 
the same irrespective of which stimulus was used (Table I). 
The time-dependence of LPS priming was also investigated (Fig. 6). Pretreat- 
ment of cells for 0-10 rain with LPS produced no augmentation of PMA induced 
20:4  release.  Preincubation  of cells for periods longer than  10 min resulted in 
enhanced PMA triggered 20:4 secretion (Fig. 6). Maximal priming was obtained 
after 50-60 min preincubation  with LPS. The time dependence of LPS priming 170  LIPOPOLYSACCHARIDE  PRIMING  OF  MACROPHAGES 
TABLE  ] 
Concentration and Time Dependence of LPS Priming of Macrophage 
for Enhanced 20:4 Metabolism 
Priming after 30 h 
Stimulus*  KI/2~  tl/~§  (fold increase) I 
ng/ml  min 
Zymosan  8.5  18  1.7 
BIgG  5.1  20  2.3 
PMA  10.8  21  3.0 
A23187  7.0  22  2.8 
Resident  peritoneal macrophages  were isolated and labeled overnight 
with [~H]20:4. The cells were then washed, and the concentration and 
time dependence of LPS priming  of the cells for enhanced 20:4 secretion 
was determined as described in the legends to Figs. 5-7. 
* Cells were challenged with zymosan (160 #g/ml), BIgG (5 mg), or PMA 
(100 ng/ml) for 120 rain, or with A23187 (10 ug/ml) for 30 min. 
* The half-maximal concentration of LPS required for priming. 
§ The preincubation time required for half-maximal activation  of 20:4 
metabolism. 
II Cells were primed with LPS and washed as described in the legend to 
Fig. 7. The cells were then challenged with the indicated stimulus after 
a further 30 h in culture. The data is expressed as the amount of 20:4 
released by LPS-primed cells divided by the amount of 20:4 released by 
cells that had not been exposed to LPS. 
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FIGURE 6.  20:4  secretion  by  macrophages  preincubated for  varying times  in  LPS. Cells 
preincubated with 100 ng/ml HSA-LPS for the times indicated were treated with 100 ng/ml 
PMA for 15 rain, after which duplicate aliquots of the medium were removed,  counted and 
assayed for 20:4 secretion as in Fig. 1. 
of the 20:4 cascade was similar regardless of which trigger was used to stimulate 
20:4 secretion (Table I). 
We also attempted to examine how long the printed state persisted. Cells were 
treated with LPS for  1 h, then washed with PD containing delipidated BSA, and 
PMA-triggered  20:4  release  was  determined (Fig.  7).  Enhanced levels of 20:4 
release  were  maintained for  at  least  30  h.  Macrophages  remained primed for 
enhanced 20:4 secretion 30 h  after addition of LPS irrespective of whether they 
were challenged with zymosan, immune complexes, PMA, or A23187 (Table I). 
These data indicate that the temporal response and concentration dependence ADEREM  ET  AL.  171 
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FICuR~ 7.  Persistence  of LPS-priming of macrophages for enhanced 20:4 secretion. The 
cells were treated with either a-MEM containing 100 ng/ml LPS (0) or with a-MEM alone 
(x). After  60 min at 37 °C in 95% air/5% COs the cells were washed 4 times  with PD containing 
delipidated HSA. The cells were then overlaid with a-MEM containing 10% FCS and [SH]- 
20:4, and after the specified times, the cells were challenged with 100 ng/ml PMA for 120 
rain, then assayed  as before (Fig. 1). 
of LPS priming is identical irrespective of which trigger is  used, and suggests 
that a common mechanism underlies LPS priming for a variety of triggers. 
Effect  of LPS on Profile  of 20:4 metabolites  Secreted  by macrophages.  Resident 
peritoneal macrophages have the capacity of oxygenate 20:4  via the cyclooxy- 
genase pathway (prostacyclin, PGE2, and HHT) and via the lipoxygenase pathway 
(LTC and HETEs) (2-5)  (Table II).  The different trigger stimulated the pro- 
duction of different 20:4  metabolites. Hence zymosan and immune complexes 
resulted in the secretion of: 6-keto-PGF~, 40%; PGE2, 26-35%; LTC, 15-25%; 
HETEs,  10%, and free 20:4,  1% (Table II). On the other hand, PMA and LPS 
(used as a trigger) only stimulated the release of the cyclooxygenase products 6- 
keto-PGFl~ (55%)  and PGEz (45%)  (Table  II).  The Ca  2+ ionopbore, A23187, 
triggered the secretion of proportionately more lipoxygenase products (6-keto- 
PGF1~, 30%; PGEz, 20%; LTC, 25%,  HETEs, 20%, and free 20:4, 5%) (Table 
II). 
Cells  primed  with  LPS  for  60  rain  and  then  challenged  with  the  stimuli 
described in Table II secreted the same profile (ratio) of 20:4 metabolites as did 
unprimed cells,  even though larger amounts of each metabolite was secreted by 
the LPS-treated cells. 
Further evidence that LPS treatment did not modulate the cyclooxygenase or 
lipoxygenase  pathways  came  from  experiments  investigating  the  exogenous 
metabolism of 20:4.  Resident peritoneal macrophages metabolize exogenously 
added 20:4 in the absence of a trigger (19) (Table I I I). Exposure of macrophages 
to 0.5 #Ci (8.3  riM) [3H]20:4  in serum-free c~-MEM for 20  min resulted in the 
production of 58% cyclooxygenase products (major species 6-keto PGFI~),  22% 
HETEs, and 20%  unreacted 20:4.  When the experiment was carried out with 
cells primed with E. coli LPS (1  ~g/ml), 56% of the label had been metabolized 172  LIPOPOLYSACCHARIDE  PRIMING  OF  MACROPHAGES 
TABLE  II 
20.'4 Metabolites Synthesized by LPS-primed and Control Macrophages, in Response to a 
Variety of Stimuli 
Percent 
Condition  aH label  6-keto-  PGE2  LTC  HETEs  Unreacted 
released  PGFt=  20:4 
Zymosan  23.3  40.9  26.0  24.7  7.7  0.7 
LPS/Zymosan  42.8  39.5  26.2  23.0  10.1  1.2 
BIgG  16.1  40.3  34.9  15.1  8.6  1.1 
LPS/BIgG  30.0  42.0  33.9  14.3  9.0  0.8 
PMA  10.8  54.0  43.6  <0.2  1.6  0.8 
LPS/PMA  37.8  53.7  44.3  <0.2  1.1  0.9 
A23187  21.4  30.7  20.5  25.1  18.9  4.8 
LPS/A 23187  41.0  33.1  21.2  23.2  17.4  5.1 
Latex  1.7  57.9  33.7  <0.2  i .9  6.5 
LPS/Latex  24.6  54.1  43.5  <0.2  1.2  1.2 
LPS alone  8.1  55.3  42.2  <0.2  2.3  0.2 
Macrophages were isolated and labeled with [SH]20:4. The cells were washed and preincubated for 
60 rain with c~-MEM containing 1 #g/ml LPS, or with c~-MEM alone. The macrophages were then 
challenged with zymosan (160 #g/ml),  BIgG (5  mg),  PMA (100 ng/ml), or latex particles for  120 
min, or with A23187 (10 #g/ml) for 30 min. The data reported for LPS alone reflects the profile of 
20:4 metabolites determined in the medium  180 min after the addition of LPS. After the cells were 
challenged for the apppropriate times with each stimulus, the medium was aspirated and extracted 
for 20:4 metabolites. Extracts were dried under N2 and chromatographed on HPLC systems 1 and 
2 as described in Materials and Methods. Values are expressed as the percent of the total [3H]20:4 
products  formed  and  calculated  on  the  basis  of discernible peaks  above  background.  The  data 
represents the mean +  SD of four determinations. 
TABLE  III 
Effect of LPS on Production of Metabolites from Exogenous 20:4 
Percent [3H]20:4  Percentage of radiolabel in medium 
Condition  incorporated by 
macrophages  Prostaglandins  HETEs  20:4 
Control  39.2 4- 6.1  57.8 _+ 8.1  22.0 -  3.1  20.2 +  4.0 
Preincubated with LPS  43.1  4- 3.2  56.2 4- 6.8  16.5 +- 1.9  27.3 "4- 5.1 
Macrophages were isolated and incubated overnight in MEM plus  10% FCS. Cultures were washed 
and preincubated for 60 min with a-MEM containing 1 •g/ml  LPS or with a-MEM alone. [3H]20:4 
(0.5 uCi, 8.3 nM) was added to the medium, and after 20 rain at 37°C the medium was removed 
and an aliquot was counted.  Macrophages were scraped into  1 ml of 0.05% Triton X-100 and the 
radiolabel content was determined.  Data are reported as duplicate determinations on  four dishes 
(mean +  SD) of the total recovered [3H]20:4.  The medium  was extracted for 20:4 metabolites as 
described in Materials and Methods. Medium extracts of duplicate 35-mm culture dishes were pooled 
and subjected to HPLC. The data represent the mean 4- SD of four determinations, and are presented 
as the percent of the total [3H]20:4 recovered in HPLC effluents. 
to cyclooxygenase  products  (mainly  6-keto-PGF~),  16% to HETEs,  and  27%  was 
unreacted  20:4  (Table  III). 
These  data  suggest  that  LPS  priming  promotes  the release  of greater  amounts 
of  20:4  from  membrane  phospholipids,  but  that  it does  not  modulate  the  20:4 
cascade  at the  level of either  the  cycloxygenase  or  lipoxygenase  pathways. ADEREM  ET  AL.  173 
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FIGURE 8.  Macrophages  primed with LPS secrete 20:4 metabolites when challenged with 
latex beads. Cells were treated and assayed  as in Fig. 1. In B, the latex particles were added 
first and LPS was added second. 
LPS Primes Macrophages to Secrete  20:4 Metabolites  in Response to Latex Beads. 
Priming with LPS also had the ability to convert a  particle without triggering 
activities into an active one. 
Latex particles were ingested by macropbages without the release and metab- 
olism of 20:4  (20),  (Fig. 8A).  However, when LPS-primed cells  ingested latex 
beads, up to 30%  of the cellular 20:4  was released (Fig. 8A).  The metabolites 
consisted solely of the cyclooxygenated products prostacyclin and PGE2 (Table 
II). The order in which the cells were exposed to LPS and latex was critical for 
the final outcome. When latex beads were added to the cells first, and LPS was 
added thereafter, no 20:4 metabolites were released (Fig. 8B). 
These data suggest that stimulus-dependent 20:4 release is composed of two 
distinct steps, a priming step and a triggering step.  LPS can prime the cell  for 
20:4 secretion, but is inefficient as a trigger. On the other hand, latex can trigger 
20:4 secretion, but is incapable of printing the cells for 20:4 secretion. 
Complement Receptors  Do Not  Trigger  20:4 Metabolite  Secretion  in  LPS-primed 
Macrophages.  The complement receptors (both C3b and C3bi) of murine resi- 
dent peritoneal macrophages have been shown to exist in one of two states. In 
the first, they are capable of binding particles opsonized with either C3b or C3bi, 
but are incapable of promoting the phagocytosis of these particles (21).  Treat- 
ment of the cells  with a  lymphokine results in their conversion to the second 
state, capable of both binding and ingesting complement-coated particles (21). 
We have shown previously (9) that neither the ligated C3b nor C3bi receptor 
is capable of triggering 20:4  secretion  irrespective of whether these receptors 
promote phagocytosis. We therefore wished to examine whether priming with 
LPS permitted these receptors to promote 20:4 secretion. 
Particles coated with the complement components C3b and C3bi were incap- 
able of triggering 20:4 metabolite secretion in either LPS-primed or untreated 
macrophages (data not shown). We next investigated the release of 20:4  from 
macrophages  treated  with  the  lymphokine (13,  21),  which  renders  the  cells 174  LIPOPOLYSACCHARIDE  PRIMING  OF  MACROPHAGES 
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FIGURE 9.  Macrophages  primed  with  LPS  do  not  secrete  20:4  metabolites  when  their 
complement receptors are  ligated.  Macrophages were  isolated,  treated with lymphokine to 
activate the complement receptors as described in Materials and Methods, and labeled with 
[~H]20:4. The cells were then washed and treated with either a-MEM containing 1 #g/ml LPS 
(O, O, I) or with a-MEM alone (VI, A, x). After 60 min at 37°C in 95% air/5% CO2 the cells 
were challenged with 5 mg of BIgM (A, I) or BlgMC (0, FI). Control cells received no further 
stimulus (x, ©). Assay procedures were as described in Fig.  1. 
capable of promoting phagocytosis via their complement receptors.  Ligation of 
C3b and C3bi receptors in such lymphokine-treated macrophages again failed to 
trigger the 20:4 cascade in either LPS-primed or unprimed cells (Fig. 9). These 
data show that release of 20:4 is not the inevitable consequence of phagocytosis 
or receptor ligation in LPS-primed macrophages.  Rather, some particles that do 
not usually induce 20:4 release (e.g., latex beads) can do so when cells are primed 
with LPS, but other particles (e.g., C3-coated beads) cannot induce 20:4 release 
in the absence or presence of EPS. 
The Role  of T  Cells in LPS Priming of 20:4 Metabolism  in Macrophages.  We 
wished to investigate  whether  LPS was acting directly on the macrophages,  or 
whether it was promoting the release of lymphokines from adherent T  cells that 
in turn primed the macrophages. 
The  protocol  for  labeling  resident  peritoneal  macrophages  with  [3H]20:4 
necesitates their culture for at least 24 h. Adherent cell populations maintained 
in culture for 24 h  contain  very few contaminating  T  lymphocytes (<5%, data 
not shown). We excluded the possibility that  these contaminating  T  cells had a 
role in  LPS-induced priming  of 20:4  metabolism  in  macrophages  in  two ways. 
First,  we  showed  that  the  addition  of  freshly  isolated  nonadherent  cells  to 
macrophage  cultures had  no effect on  LPS priming  (data not shown).  Second, 
we demonstrated  that  peritoneal  macrophages  isolated from  nude mice (Swiss- 
Webster nu/nu),  which  lack  mature  T  lymphocytes, respond  normally to  LPS 
(Fig.  10). 
Mature T  lymphocytes therefore do not appear to have a role in LPS priming 
of macrophages for enhanced 20:4 secretion. 
Discussion 
Murine  resident  peritoneal  macrophages  constitutively secrete  low levels of 
20:4 metabolites including PGI2, PGE2, and LTC (2-5). When these cells interact 
with immune complexes, zymosan, PMA, or the Ca  2+ ionophore A23187, phos- 
pholipases are activated and the cells release large quantities of 20:4 metabolites. 
LPS has also been  shown  (22)  to trigger  the  secretion of smaller  quantities  of 
20:4  metabolites consisting  exclusively of prostaglandins.  We now report  that, 
while  LPS  alone  is  a  very  poor  trigger  of the  20:4  cascade,  it  does  prime 
macrophages  for greatly  enhanced  20:4  metabolite secretion  when  these  cells 
are challenged with a  second stimulus.  Thus preincubation  of macrophages for ADEREM  ET  AL.  175 
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FIGURE 10.  Effect of LPS on  zymosan-induced 20:4 secretion from resident peritoneal 
macrophages from nude mice (Swiss-Webster  nu/nu). The cells were overlaid with either a- 
MEM containing 100 ng/ml LPS (X, 0) or with a-MEM alone (£x, O), then challenged with 
160 ug/ml zymosan as indicated (x, A). 
45 rain  in a  medium  containing  50 ng/ml  LPS results in a  three-  to eight-fold 
enhancement of 20:4 metabolite secretion in response to a variety of triggers. 
LPS  has  multiple  effects  on  mononuclear  phagocytes  (reviewed  in  23).  It 
enhances tumoricidal activity (24, 25), triggers the synthesis and release of tumor 
necrosis factor (26),  hydrolytic enzymes (27,  28),  growth  factors (29),  comple- 
ment components (30), and  prostaglandins  (22).  Furthermore,  while LPS does 
not trigger  the  release of reactive oxygen intermediates  from  macrophages,  it 
does prime  macrophages for enhanced  secretion of H202 and  O~- when  subse- 
quently stimulated with PMA (31). 
Direct  triggering  of 20:4  secretion  by  LPS occurs by a  mechanism  distinct 
from  that  which  results  in  the  priming  of  macrophages  for  enhanced  20:4 
secretion to other stimuli.  First, the K,~, for priming is  10 ng/ml  LPS, while that 
for triggering  is 500 ng/ml.  Second, the cells are fully primed by 50 rain, while 
LPS-induced 20:4  secretion only commences after 90 rain.  Finally,  in  work to 
be reported elsewhere, we show that there are different structural requirements 
for priming  and triggering.  The ester-linked  3-OH myristic acid of the lipid A 
portion of LPS is necessary for triggering but not for priming of 20:4 secretion. 
The  profile  of 20:4  metabolites  secreted  by  macrophages  depends  on  the 
nature  of  the  stimulus  (20,  32).  While  LPS  is  capable  of potentiating  20:4 
metabolite secretion,  it does not result in an alteration  in  the ratio of products 
released. This suggests that it is the phospholipase activity and not the cycloox- 
ygenase or lipoxygenase pathways that are regulated by LPS treatment. 
The mechanism by which LPS primes macrophages for heightened 20:4 release 
is not clear. LPS might act by increasing the affinity of receptors for their ligands, 
increasing the number of receptors, or by causing rearangement of receptors on 
the cell surface.  It seems likely, however, that  LPS-priming involves steps distal 
to  receptor-ligand  binding,  since  binding  and  phagocytosis of zymosan,  IgG- 
opsonized  erythrocytes, and  latex  is  unchanged  in  LPS-treated  cells (data  not 176  LIPOPOLYSACCHARIDE  PRIMING  OF  MACROPHAGES 
shown). Moreover, LPS appears to act on a  step that follows ligation.  Previous 
work (33) showed that triggering of the 20:4 cascade by surface-bound ligands 
requires Na  + influx, a protein synthetic step, and a rise in intracellular Ca  ~+, in 
that order. PMA and A23187 initiate the cascade at steps following the ligation 
step.  Since LPS changes PMA and A23187  responses, it must affect an event 
following ligand-receptor binding. 
Further evidence that LPS affects an event following receptor ligation comes 
from  kinetic  studies.  When  unprimed  cells are  stimulated,  secretion of 20:4 
metabolites commences only after a  lag phase.  This  lag phase  is  significantly 
shortened in LPS-treated cells. Treatment with LPS may thus speed and poten- 
tiate  20:4  release  by  establishing  one  or  more  preconditions  necessary  for 
activation of the phospholipase. Further support for this hypothesis is provided 
by the ability of LPS to render macrophages responsive to latex particles. Latex 
particles are ingested by macrophages without  the release and  metabolism of 
20:4 (20 and Fig. 8).  However, when LPS-primed cells ingest latex beads, up to 
30%  of the cellular 20:4  is released as PGI2 and PGE2 (Fig.  8).  For LPS to be 
effective, it has to be added to the cells at least 45  rain before the latex.  This 
suggests  that  two  categories of signals  might  be  required  for  20:4  secretion, 
priming signals and triggering signals.  Zymosan and  immune complexes may 
establish both,  latex might be incapable of establishing the priming signals but 
capable of generating the triggering signals,  and  ligation of the C3  receptors 
establishes neither. 
There is a precedent for LPS rendering macrophages responsive to a second 
stimulus. Neither LPS nor latex is capable of stimulating macrophages to secrete 
plasminogen  activator  from  resident peritoneal  cells.  However,  while  macro- 
phages primed  by  intraperitoneal  injection  of LPS  do  not  secrete significant 
amounts of plasminogen activator, they do so when challenged with latex (28). 
Little is known about the molecular mechanisms by which LPS might trigger 
such diverse biological effects. The molecule must first insert into  the plasma 
membrane or bind to specific membrane receptors. It must then interact with 
enzyme systems involved in cellular signalling. LPS-priming of macrophages for 
enhanced 20:4  secretion may reflect increased synthesis or induction of phos- 
pholipases, or might be due to posttranslational modification of proteins involved 
in signalling. LPS has been shown (34) to activate the protein kinase C in vitro, 
and we have shown (unpublished results) that LPS triggers the phosphorylation 
of a  large number of proteins.  However, since PMA, which also activates the 
protein kinase C,  does not prime  macrophages to  secrete 20:4  metabolites in 
response to latex (data not shown), LPS-induced priming must be more compli- 
cated than a mere activation of protein kinase C. We have recently (A. Aderem, 
E.  Pure, and Z. A. Cohn, manuscript in preparation) found that LPS promotes 
the specific myristoylation of three macrophage proteins with a time and concen- 
tration  dependence compatible with  it  having a  role in  LPS-induced priming. 
We are  currently investigating whether the  acylation of proteins  involved in 
celullar  regulation  promotes  their  attachment  to  the  plasma  membrane and 
consequently facilitates signal transduction. ADEREM ET  AL.  177 
Summary 
Preincubation of resident peritoneal  macrophages with  10-100  ng/mi LPS 
for 60 rain resulted in the cells becoming primed for enhanced (three- to eightfold 
higher) arachidonic acid (20:4) secretion in response to a variety of triggers. The 
half-maximal concentration of LPS required for priming was 10 ng/ml irrespec- 
tive  of whether  the  trigger  was  particulate  (examples:  zymosan  or  immune 
complexes) or soluble (such as  PMA or A23187).  Similarly, the time required 
for  half-maximal priming  of macrophages  was  20  min  irrespective  of which 
trigger was used. The primed state persisted for at least 30 h. 
LPS-priming of macrophages  also  affected the  kinetics  of 20:4  metabolite 
secretion.  The  lag  phase  characteristically observed  when  20:4  secretion  is 
triggered  was  reduced  in  LPS-primed  ceils.  Furthermore,  LPS-primed cells 
secreted  20:4  metabolites when  challenged with latex beads,  while  unprimed 
cells did not. These data suggest that stimuli such as zymosan, which elicit 20:4 
secretion in macrophages, promote two signals, a priming signal and a triggering 
signal. LPS is capable of establishing the priming signal but not the triggering 
signal, while latex promotes the triggering signal but is unable to prime the cells 
for 20:4 release. 
LPS did not effect the profile of 20:4 metabolites secreted in response to any 
of the  triggers,  nor  did  it  effect  the  profile  of products  synthesized  from 
exogenously added 20:4, suggesting that it did not regulate the 20:4 cascade at 
the level of either the cyclooxygenase or lipoxygenase pathways. 
Macrophages respond to LPS without the intervention of T  lymphocytes, since 
the macrophages from nude mice could be primed for enhanced 20:4 secretion. 
We thank Matthew M. Keum for excellent technical assistance. 
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